These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10803504)

  • 61. Isolation of murine hematopoietic stem cells and progenitor cells.
    Ema H; Morita Y; Nakauchi H; Matsuzaki Y
    Curr Protoc Immunol; 2005 Jul; Chapter 22():Unit 22B.1. PubMed ID: 18432947
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Analysis of human hematopoietic stem cell populations.
    Murray L; DiGiusto D; Chen B; Chen S; Combs J; Conti A; Galy A; Negrin R; Tricot G; Tsukamoto A
    Blood Cells; 1994; 20(2-3):364-9; discussion 369-70. PubMed ID: 7538340
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Normal and leukemic CD34-negative human hematopoietic stem cells.
    Bonnet D
    Rev Clin Exp Hematol; 2001 Mar; 5(1):42-61. PubMed ID: 11486732
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The CD34+Thy1+ cell population: are they all stem cells?
    McNiece I
    Exp Hematol; 2000 Dec; 28(12):1312-4. PubMed ID: 11188921
    [No Abstract]   [Full Text] [Related]  

  • 65. Isolation of CD34-positive hematopoietic progenitor cells.
    Shpall EJ; Gehling U; Cagnoni P; Purdy M; Hami L; Gee AP
    Immunomethods; 1994 Dec; 5(3):197-203. PubMed ID: 7540099
    [No Abstract]   [Full Text] [Related]  

  • 66. Quantitation of CD34+ cells.
    Serke S; Huhn D
    Blood; 1992 Sep; 80(6):1628-30. PubMed ID: 1381631
    [No Abstract]   [Full Text] [Related]  

  • 67. An in vitro study of hematopoietic progenitor cells from peripheral blood of rabbits.
    Gómez-Ochoa P; Miana-Mena FJ; Muñoz MJ; Cativiela E; Gómez F
    Can J Vet Res; 2005 Oct; 69(4):309-12. PubMed ID: 16479731
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Clinical analysis of 8 cases of refractory hematopoietic reconstitution after haploid hematopoietic stem cell transplantation treated with purified donor CD34-selected hematopoietic stem cells].
    He Y; Ma R; Wang HF; Zhang YY; Lyu M; Mo XD; Yan CH; Wang Y; Zhang XH; Xu LP; Liu KY; Huang XJ; Sun YQ
    Zhonghua Xue Ye Xue Za Zhi; 2023 Dec; 44(12):1027-1031. PubMed ID: 38503527
    [No Abstract]   [Full Text] [Related]  

  • 69. Establishing humanized mice using stem cells: maximizing the potential.
    Bernard D; Peakman M; Hayday AC
    Clin Exp Immunol; 2008 Jun; 152(3):406-14. PubMed ID: 18435804
    [TBL] [Abstract][Full Text] [Related]  

  • 70. CD34 cell separation: from basic research to clinical applications.
    Nadali G; de Wynter EA; Testa NG
    Int J Clin Lab Res; 1995; 25(3):121-7. PubMed ID: 8562973
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The haemopoietic progenitor cell.
    Goyal R; Parikh PM
    Indian J Med Sci; 1995 Oct; 49(10):237-48. PubMed ID: 8772828
    [No Abstract]   [Full Text] [Related]  

  • 72. The real CD34+ events: simplicity versus accuracy and flexibility.
    Gratama JW; Keeney M; Sutherland DR; Papa S
    Exp Hematol; 1999 Jun; 27(6):975-7. PubMed ID: 10378886
    [No Abstract]   [Full Text] [Related]  

  • 73. New approaches to clinical harvest manipulation.
    Sharp JG
    Cytotherapy; 2000; 2(5):393-4. PubMed ID: 12044235
    [No Abstract]   [Full Text] [Related]  

  • 74. A functional interaction between the CCR5 and CD34 molecules expressed in hematopoietic cells can support (or even promote) the development of cancer.
    Kulmann-Leal B; Ellwanger JH; Chies JAB
    Hematol Transfus Cell Ther; 2020; 42(1):70-76. PubMed ID: 31822447
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Alcohol abuse and disorder of granulopoiesis.
    Shi X; DeLucia AL; Bao J; Zhang P
    Pharmacol Ther; 2019 Jun; 198():206-219. PubMed ID: 30831129
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors.
    Meyerrose T; Olson S; Pontow S; Kalomoiris S; Jung Y; Annett G; Bauer G; Nolta JA
    Adv Drug Deliv Rev; 2010 Sep; 62(12):1167-74. PubMed ID: 20920540
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.
    Li JM; Giver CR; Lu Y; Hossain MS; Akhtari M; Waller EK
    Immunotherapy; 2009 Jul; 1(4):599-621. PubMed ID: 20191089
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Contribution of human hematopoietic stem cells to liver repair.
    Zhou P; Wirthlin L; McGee J; Annett G; Nolta J
    Semin Immunopathol; 2009 Sep; 31(3):411-9. PubMed ID: 19533133
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Stem cells for liver tissue repair: current knowledge and perspectives.
    Lysy PA; Campard D; Smets F; Najimi M; Sokal EM
    World J Gastroenterol; 2008 Feb; 14(6):864-75. PubMed ID: 18240343
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cytokine and integrin stimulation synergize to promote higher levels of GATA-2, c-myb, and CD34 protein in primary human hematopoietic progenitors from bone marrow.
    Dao MA; Nolta JA
    Blood; 2007 Mar; 109(6):2373-9. PubMed ID: 17095623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.